ANTHONY R CHASE
CIK 1223756 · last filed 2026-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.88M
Companies
10
Total Filings
137
Lifetime Open-Market Net
-$653.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NBR | Director | 15,408 | $88.57 | $1.36M | $0 | 12 | 2026-06-03 |
| CFR | Director | 1 | $167.56 | $168 | $109 | 8 | 2026-05-27 |
| LYB | Director | 13,603 | $63.15 | $859.0K | $255 | 23 | 2026-05-26 |
| PARR | Director | 10,529 | $75.01 | $789.8K | $0 | 13 | 2024-10-08 |
| Heritage-Crystal Clean, Inc. (HCCI) Delisted | Director | 1,641 | $45.51 | $74.7K | $0 | 1 | 2021-05-05 |
| APC | Director | 0 | $18.55 | $0 | $288.5K | 13 | 2019-08-09 |
| PARAGON OFFSHORE PLC (PGN) Delisted | Director | 19,616 | — | — | $0 | 5 | 2015-05-05 |
| SRPT | Director | 67,194 | $18.29 | $1.23M | -$389.7K | 11 | 2015-03-03 |
| WES | Director | 13,120 | $48.77 | $639.9K | -$880.6K | 19 | 2013-12-04 |
| Sarepta Therapeutics, Inc. (AVII) Delisted | Director | 69,411 | — | — | $328.1K | 8 | 2011-09-14 |
Recent Filings · Page 11 of 14
137 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-11-16 | WES | Buy (P) | +3,342 | $100.0K | EDGAR |
| 2010-08-13 | — | Disp (D) | −40,316 | $0 | |
| 2010-08-05 | — | Mixed | +17,205 | $13 | |
| 2010-06-10 | Sarepta Therapeutics, Inc. (AVII) Delisted | Buy (P) | +46,500 | $65.9K | EDGAR |
| 2010-05-26 | WES | Grant (A) | — | $0 | EDGAR |
| 2010-05-24 | Sarepta Therapeutics, Inc. (AVII) Delisted | Buy (P) | +50,000 | $66.5K | EDGAR |
| 2010-05-21 | WES | Exer (M) | +4,660 | $97.8K | EDGAR |
| 2010-05-18 | Sarepta Therapeutics, Inc. (AVII) Delisted | Buy (P) | +29,607 | $42.1K | EDGAR |
| 2010-05-14 | Sarepta Therapeutics, Inc. (AVII) Delisted | Buy (P) | +96,000 | $129.6K | EDGAR |
| 2010-05-14 | Sarepta Therapeutics, Inc. (AVII) Delisted | — | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.